Literature DB >> 773301

Safety of the bolus administration of gentamicin.

J Mendelson, J Portnoy, V Dick, M Black.   

Abstract

A study was done to assess the safety of gentamicin administration by a bolus method. A total of 63 patients were randomly treated with intravenous gentamicin by bolus administration (3 to 5 min) and by slow infusion (2 h). Serum gentamicin levels were measured. Renal and audiovestibular function were monitored. Pure-tone audiometry was performed at the beginning, on day 3, and at the end of therapy. The study revealed that the bolus administration was safe and nontoxic.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 773301      PMCID: PMC429589          DOI: 10.1128/AAC.9.4.633

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  5 in total

1.  R-factor mediated gentamicin resistance: A new enzyme which modifies aminoglycoside antibiotics.

Authors:  R Benveniste; J Davies
Journal:  FEBS Lett       Date:  1971-05-20       Impact factor: 4.124

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  The use of gentamicin intravenously.

Authors:  A B Nielsen; S Elb
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1973

4.  Reflections on the clinical pharmacology of gentamicin.

Authors:  W L Hewitt
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1973

5.  Pharmacology of gentamicin in the biliary tract of humans.

Authors:  J Mendelson; J Portnoy; H Sigman
Journal:  Antimicrob Agents Chemother       Date:  1973-11       Impact factor: 5.191

  5 in total
  8 in total

1.  Kill kinetics and regrowth patterns of Pseudomonas aeruginosa exposed to concentration-time profiles of tobramycin simulating in vivo infusion and bolus dosing.

Authors:  P J Wood; L L Ioannides-Demos; E B Bastone; W J Spicer; A J McLean
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

2.  The anaesthetist as determinant factor of quality of surgical antimicrobial prophylaxis. A survey in a university hospital.

Authors:  I C Gyssens; J T Knape; G Van Hal; J W ver der Meer
Journal:  Pharm World Sci       Date:  1997-04

3.  Intravenous Push Administration of Antibiotics: Literature and Considerations.

Authors:  Samantha Spencer; Heather Ipema; Patricia Hartke; Courtney Krueger; Ryan Rodriguez; Alan E Gross; Michael Gabay
Journal:  Hosp Pharm       Date:  2018-03-08

4.  Kill kinetics and regrowth patterns of Escherichia coli exposed to gentamicin concentration-time profiles simulating in vivo bolus and infusion dosing.

Authors:  E B Bastone; S C Li; L L Ioannides-Demos; W J Spicer; A J McLean
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

5.  Gentamicin intravenous infusion rate: effect on interstitial fluid concentration.

Authors:  A J Kozak; D N Gerding; L R Peterson; W H Hall
Journal:  Antimicrob Agents Chemother       Date:  1977-11       Impact factor: 5.191

Review 6.  Why monitor serum levels of gentamicin?

Authors:  M Barza; M Lauermann
Journal:  Clin Pharmacokinet       Date:  1978 May-Jun       Impact factor: 6.447

7.  [Gentamicin concentrations in cerebrospinal fluid of patients with inflamed and uninflamed meninges (author's transl)].

Authors:  O Brückner; M Alexander; F Martens
Journal:  Infection       Date:  1980       Impact factor: 3.553

8.  Netilmicin and gentamicin: comparative pharmacology in humans.

Authors:  L J Riff; G Moreschi
Journal:  Antimicrob Agents Chemother       Date:  1977-04       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.